HNF4A and type 2 diabetes mellitus: Targeting the inhibition of HNF4α has become a novel strategy for T2DM treatment, and several HNF4α-targeted compounds such as flavonoid luteolin and 4-nitro-6-hydroxyflavone have been determined to be able to improve glucose homeostasis [49, 50].